Trx Biosciences Limited
11986839
Healthy
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/12/2024
micro entity
Next accounts due
30/09/2026
Confirmation statement
Last: 08/05/2026
Due 22/05/2027
Industry
Officers
director · Since 10/05/2021
DIRECTOR
BRITISH · UNITED KINGDOM · Age 65
Also on 5 other boards
director · Since 10/05/2021
RESEARCH SCIENTIST
BRITISH · UNITED KINGDOM · Age 52
Also on 2 other boards
director · Since 10/05/2021
INVESTOR
BRITISH · ENGLAND · Age 64
Also on 5 other boards
Persons with Significant Control
Biocopea Limited
London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH
Notified 09/05/2019
CompanyRankvs 329+ SIC 72110 peers76
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£316k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£293k
Working capital
Current Assets
£363k
Current Liabilities
£71k
Fixed Assets
£23k
Tax at Year End(2022)
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit | Est. Revenue |
|---|---|---|---|
| 2024 | 5.14 | -£52k | — |
| 2023 | 6.75 | -£132k | — |
| 2022 | 3.27 | -£228k | £10k |
| 2021 | 13.16 | — | £553k |
Derived from filed accounts. Not audited figures.